Membrane-bound Fas ligand only is essential for Fas-induced apoptosis

Nature

Volumn 461, Issue 7264, 2009, Pages 659-663

  O Reilly, Lorraine A ^a   Tai, Lin ^a   Lee, Lily ^a   Kruse, Elizabeth A ^a,b   Grabow, Stephanie ^a,b   Fairlie, W Douglas ^a,b   Haynes, Nicole M ^a   Tarlinton, David M ^c   Zhang, Jian Guo ^a   Belz, Gabrielle T ^a   Smyth, Mark J ^a   Bouillet, Philippe ^c   Robb, Lorraine ^a   Strasser, Andreas ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MEMBRANE PROTEIN;

APOPTOSIS; CANCER; GENE EXPRESSION; HORMONE; IMMUNE RESPONSE; IMMUNITY; LIGAND; MEMBRANE; RODENT; SECRETION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; C57BL 6 MOUSE; CARCINOGENESIS; CELL KILLING; HISTIOCYTIC SARCOMA; HYPERGAMMAGLOBULINEMIA; KIDNEY INJURY; LYMPHADENOPATHY; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD95; APOPTOSIS; CELL MEMBRANE; CYTIDINE DEAMINASE; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GLOMERULONEPHRITIS; HISTIOCYTIC SARCOMA; HYPERGAMMAGLOBULINEMIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHATIC DISEASES; MICE; MICE, INBRED C57BL; MUTATION; SPLENOMEGALY; T-LYMPHOCYTES;

MUS;

EID: 70349694386     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08402     Document Type: Article

References (41)

1. Hughes, P. D. et al. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 28, 197-205 (2008)
2. Hutcheson, J. et al. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28, 206-217 (2008)
3. Weant, A. E. et al. Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD81 T cell contraction. Immunity 28, 218-230 (2008)
4. Krammer, P. H. CD95s deadly mission in the immune system. Nature 407, 789-795 (2000)
5. Peter, M. E. et al. The CD95 receptor: apoptosis revisited. Cell 129, 447-450 (2007)
6. Watanabe-Fukunaga, R. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279 (1992)
7. Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976 (1994)
8. Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349 (1995)
9. Fisher, G. H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946 (1995)
10. Trambas, C. M. & Griffiths, G. M. Delivering the kiss of death. Nature Immunol. 4, 399-403 (2003)
11. Schulte, M. et al. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ. 14, 1040-1049 (2007)
12. Schneider, P. et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187, 1205-1213 (1998)
13. Tanaka, M., Itai, T., Adachi, M. & Nagata, S. Downregulation of Fas ligand by shedding. Nature Med. 4, 31-36 (1998)
14. Hohlbaum, A. M., Moe, S. & Marshak-Rothstein, A. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival. J. Exp. Med. 191, 1209-1219 (2000)
15. Siegel, R. M. et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288, 2354-2357 (2000)
16. Chen, J.-J., Sun, Y. & Nabel, G. J. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282, 1714-1717 (1998)
17. Wilson, N. S., Dixit, V. & Ashkenazi, A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nature Immunol. 10, 348-355 (2009)
18. Ahn, J. H. et al. Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NFkB- dependent gene expression. J. Biol. Chem. 276, 47100-47106 (2001)
19. Xiao, S., Jodo, S., Sung, S. S., Marshak-Rothstein, A. & Ju, S. T. A novel signaling mechanism for soluble CD95 ligand. Synergy with anti-CD95 monoclonal antibodies for apoptosis and NF-kB nuclear translocation. J. Biol. Chem. 277, 50907-50913 (2002)
20. Oliveira, J. B. et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA 104, 8953-8958 (2007)
21. Kono, D. H. & Theofilopoulos, A. N. Genetic susceptibility to spontaneous lupus in mice. Curr. Dir. Autoimmun. 1, 72-98 (1999)
22. Watanabe, D., Suda, T., Hashimoto, H. & Nagata, S. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14, 12-18 (1995)
23. Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809 (1993)
24. Huang, D. C. et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL. Proc. Natl Acad. Sci. USA 96, 14871-14876 (1999)
25. Strand, S. et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligandexpressing tumor cells-a mechanism of immune evasion? Nature Med. 2, 1361-1366 (1996)
26. Fredrickson, T. N. & Harris, A. W. Atlas of Mouse Hematopathology (Harwood Academic, 2000)
27. Frith, C. H. & Wiley, L. D. Morphologic classification and correlation of incidence of hyperplastic and neoplastic hematopoietic lesions in mice with age. J. Gerontol. 36, 534-545 (1981)
28. Suzuki, I. & Fink, P. J. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187, 123-128 (1998) (Pubitemid 28044827)
29. Sun, M. & Fink, P. J. A new class of reverse signaling costimulators belongs to the TNF family. J. Immunol. 179, 4307-4312 (2007)
30. Karray, S. et al. Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele. J. Immunol. 172, 2118-2125 (2004)
31. Schwenk, F., Baron, U. & Rajewsky, K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080-5081 (1995)
32. Phillips, J. M., OReilly, L., Bland, C., Foulis, A. K. & Cooke, A. Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration. Diabetes 56, 634-640 (2007)
33. Pileri, S. A. et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41, 1-29 (2002)
34. Blott, E. J., Bossi, G., Clark, R., Zvelebil, M. & Griffiths, G. M. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J. Cell Sci. 114, 2405-2416 (2001)
35. Naik, S., Vremec, D., Wu, L., OKeeffe, M. & Shortman, K. CD8a1 mouse spleen dendritic cells do not originate from the CD8 a-dendritic cell subset. Blood 102, 601-604 (2003)
36. Hibbs, M. L. et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301-311 (1995)
37. Lyons, A. B. & Parish, C. R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171, 131-137 (1994)
38. Kilbourne, E. D. Future influenza vaccines and the use of genetic recombinants. Bull. WHO 41, 643-645 (1969)
39. Flynn, K. J. et al. Virus-specific CD81 T cells in primary and secondary influenza pneumonia. Immunity 8, 683-691 (1998)
40. Belz, G. T., Xie, W., Altman, J. D. & Doherty, P. C. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(1) T-cell response is much less apparent following secondary challenge. J. Virol. 74, 3486-3493 (2000)
41. Belz, G. T., Xie, W. & Doherty, P. C. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD81 T cell responses. J. Immunol. 166, 4627-4633 (2001)